Evidence map›Paper›PMID 34631628›Full record

ArticleFrontiers in pediatrics2021

Mechanistic Coupling of a Novel

Paola Mian, Bridget Nolan, John N van den Anker, Kristel van Calsteren, Karel Allegaert, Nisha Lakhi, André Dallmann

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 5 countries.

Paola MianDepartment of Clinical Pharmacy, Medisch Spectrum Twente, Enschede, Netherlands.
Bridget NolanDepartment of Obstetrics and Gynecology, Richmond University Medical Center, Staten Island, NY, United States.
John N van den AnkerDivision of Clinical Pharmacology, Children's National Hospital, Washington, DC, United States.
Kristel van CalsterenDepartment of Development and Regeneration, KU Leuven, Leuven, Belgium.
Karel AllegaertDepartment of Development and Regeneration, KU Leuven, Leuven, Belgium.
Nisha LakhiDepartment of Obstetrics and Gynecology, Richmond University Medical Center, Staten Island, NY, United States.
André DallmannPharmacometrics/Modeling and Simulation, Research and Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany.
KU Leuven · BERichmond University Medical Center · USBayer (Germany) · DEChildren's National · USMedisch Spectrum Twente · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Little is known about placental drug transfer and fetal pharmacokinetics despite increasing drug use in pregnant women. While physiologically based pharmacokinetic (PBPK) models can help in some cases to shed light on this knowledge gap, adequate parameterization of placental drug transfer remains challenging. A novel

Indexed as

acetaminophenex vivo cotyledon perfusionmaternal-fetalphysiologically-based pharmacokineticsplacental transferpregnancy

Identifiers

PMID34631628
PMCPMC8496351
OpenAlexW3204464366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.